Paper39633593
TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.
Wang H and 6 others. Biomark Med, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China. Papers, record 39633593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39633593
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| ErbB Receptors | Major topic |
| Lung Neoplasms | Major topic |
| Mutation | Major topic |
| Humans | |
| Female | |
| Male | |
| China | |
| Middle Aged | |
| Prognosis | |
| Retrospective Studies | |
| Aged | |
| Biomarkers, Tumor | |
| Adult |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33796457 | The Association of microRNA-34a With High Incidence and Metastasis of Lung Cancer in Gejiu and Xuanwei Yunnan. | Front Oncol | 2021 | https://conductscience.org/library/papers/33796457 | PubMed |
| 2 | 34406546 | Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. | Gastric Cancer | 2021 | https://conductscience.org/library/papers/34406546 | PubMed |
| 3 | 33224870 | Distinct EGFR Mutation Pattern in Patients With Non-Small Cell Lung Cancer in Xuanwei Region of China: A Systematic Review and Meta-Analysis. | Front Oncol | 2020 | https://conductscience.org/library/papers/33224870 | PubMed |
| 4 | 31518876 | The characteristics of lung cancer in Xuanwei County: A review of differentially expressed genes and noncoding RNAs on cell proliferation and migration. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/31518876 | PubMed |
| 5 | 23224416 | The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, China. | Front Med | 2012 | https://conductscience.org/library/papers/23224416 | PubMed |
| 6 | 32945604 | Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review. | Thorac Cancer | 2020 | https://conductscience.org/library/papers/32945604 | PubMed |
| 7 | 28882180 | High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods. | J Exp Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28882180 | PubMed |
| 8 | 32450353 | Particle-induced oxidative damage by indoor size-segregated particulate matter from coal-burning homes in the Xuanwei lung cancer epidemic area, Yunnan Province, China. | Chemosphere | 2020 | https://conductscience.org/library/papers/32450353 | PubMed |
| 9 | 31208370 | EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer. | BMC Cancer | 2019 | https://conductscience.org/library/papers/31208370 | PubMed |
| 10 | 33535978 | Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma. | BMC Cancer | 2021 | https://conductscience.org/library/papers/33535978 | PubMed |
| 11 | 30098332 | Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics. | Exp Cell Res | 2018 | https://conductscience.org/library/papers/30098332 | PubMed |
| 12 | 34603786 | Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden. | J Adv Res | 2021 | https://conductscience.org/library/papers/34603786 | PubMed |
| 13 | 34625620 | CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/34625620 | PubMed |
| 14 | 25223911 | Household air pollution and lung cancer in China: a review of studies in Xuanwei. | Chin J Cancer | 2014 | https://conductscience.org/library/papers/25223911 | PubMed |
| 15 | 31930049 | Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma. | Ann Transl Med | 2019 | https://conductscience.org/library/papers/31930049 | PubMed |
| 16 | 35020204 | Cancer statistics, 2022. | CA Cancer J Clin | 2022 | https://conductscience.org/library/papers/35020204 | PubMed |
| 17 | 12048270 | Household stove improvement and risk of lung cancer in Xuanwei, China. | J Natl Cancer Inst | 2002 | https://conductscience.org/library/papers/12048270 | PubMed |
| 18 | 12650907 | Mutation spectra of smoky coal combustion emissions in Salmonella reflect the TP53 and KRAS mutations in lung tumors from smoky coal-exposed individuals. | Mutat Res | 2003 | https://conductscience.org/library/papers/12650907 | PubMed |
| 19 | 23470965 | Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23470965 | PubMed |
| 20 | 25435280 | HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer. | Mol Oncol | 2015 | https://conductscience.org/library/papers/25435280 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42038348 | Unveiling the prognostic and immunotherapeutic role of Tregs in lung cancer using integrated analysis of single-cell and bulk RNA-sequencing. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42038348 | PubMed |
| 41132967 | Molecular and clonal evolution of primary lesions vs. brain metastasis in EGFR-mutated NSCLC: a retrospective cohort study. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/41132967 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39633593
GET https://conductscience.org/api/papers/v1/39633593/references?page=2